Schizophrenia patients do not know all the treatments available

Schizophrenia is a chronic and complex brain disorder with symptoms that can be acute that can create disabilities and affect the patient's daily life. The prevalence of the disease is similar throughout the world - about one in 100 people will be affected by schizophrenia before the age of 60, and men are more likely to suffer from this condition. The exact causes of schizophrenia are not known, but it is assumed that a combination of genetic, environmental or environmental factors acts together and generates this condition. Symptoms of schizophrenia include hallucinations, delirium, lack of an emotional response, withdrawal from social life / depression, apathy and lack of motivation or initiative. A new study by pharmaceutical company Jenssen shows that one-third of psychiatrists (34%) postpone to discuss with their schizophrenic patients all the available therapeutic options. The study also indicated that 22% of psychiatrists limit the discussion of therapeutic options in order not to affect the stability of the relationship they have with those they treat, an important aspect of over 80% of those interviewed.

A study in 2016 involving 166 patients with schizophrenia showed that more than a quarter of the participants (27%) did not think they were informed about all the therapeutic options and a similar percentage (23%). . This also means to be informed about the various therapeutic options, with the advantages and disadvantages of each one, Sorin Pletea, Head of the Clinical Section of Psychiatry No. 14 at the Open discussions between healthcare professionals and their patients are essential in the decision-making process, The results of the study, however, highlight an optimistic view of psychiatrists regarding the future of their schizophrenic patients: 85% of psychiatrists believe that continuing patients can maintain functional interpersonal relationships, and 71% believe that patients continuing treatment . The study brought together 347 psychiatrists from France, Germany, Italy, Spain, the UK, Hungary, Sweden and Turkey.

Doctors who participated in the online study had a 3 to 35 year practice experience and treated at least 20 patients living with schizophrenia. .